Interview with Neil Warma, president and CEO of Genexine

Genexine’s Neil Warma talks to Scrip’s Jung Won Shin about the company’s strategy, pipeline and plans and the wider environment for Korean biopharma firms looking to go global. From Science To Commercialization: How Genexine Is Making The Shift https://scrip.pharmaintelligence.informa.com/SC147834/From-Science-To-Commercialization-How-Genexine-Is-Making-The-Shift